pharmaceutical

Leveraged & Inverse Channel

PILL Hasn't Been a Bitter ETF to Swallow The Past Month

PILL Hasn’t Been a Bitter ETF to Swallow The Past Month

By Ben HernandezDecember 23, 2020

Tactical Allocation Channel

4 ETFs to Consider with Big Pharma on the Senate Hot Seat

4 ETFs to Consider with Big Pharma on the Senate’s Hot Seat

By Ben HernandezApril 9, 2019

'PILL' ETF Gains on $21.4B GE Biopharma Business Sale

‘PILL’ ETF Gains on $21.4B GE Biopharma Business Sale

By Ben HernandezFebruary 25, 2019

A 'PILL' ETF to Cure Ailing Portfolios

A ‘PILL’ ETF to Cure Ailing Portfolios

By Ben HernandezJuly 27, 2018